The Ahmed Versus Baerveldt Study: 5-Year Outcomes
Anti-VEGF Therapies for AMD Did Not Raise the Risk of MI, Stroke, or Death
Clinical Spectrum and Pathogenesis of True Exfoliation Syndrome
Retinal Injuries in Children Secondary to Handheld Lasers
Fixed-Dose Carteolol/Latanoprost Combination: Tolerability and Efficacy
The Auckland Cataract Study: Risk Stratification for Phacoemulsification Surgery
Public Attitudes About Eye and Vision Health
Chemical Ocular Burns: U.S. Epidemiologic Trends
Omega-3 Fatty Acids Reduce the Risk of Diabetic Retinopathy
Adalimumab for Prevention of Uveitic Flare in Patients With Inactive Noninfectious Uveitis
Adalimumab in Patients With Active Noninfectious Uveitis
Pupil Expansion Devices for Small-Pupil Cataract Surgery
Advertisement
Look out for the early signs and symptoms of this rare disease.
Explore TEPEZZA now.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2021 Horizon Therapeutics plc P-TEP-01315 08/21